Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016068173> ?p ?o ?g. }
- W2016068173 endingPage "226" @default.
- W2016068173 startingPage "220" @default.
- W2016068173 abstract "Preclinical and epidemiologic studies suggest a protective effect of statins on Alzheimer disease (AD). Experimental evidence indicates that some statins can cross the blood-brain barrier, alter brain cholesterol metabolism, and may ultimately decrease the production of amyloid-β (Aβ) peptide. Despite these promising leads, clinical trials have yielded inconsistent results regarding the benefits of statin treatment in AD. Seeking to detect a biological signal of statins effect on AD, we conducted a 12-week open-label trial with simvastatin 40 mg/d and then 80 mg/d in 12 patients with AD or amnestic mild cognitive impairment and hypercholesterolemia. We quantified cholesterol precursors and metabolites and AD biomarkers of Aβ and tau in both plasma and cerebrospinal fluid at baseline and after the 12-week treatment period. We found a modest but significant inhibition of brain cholesterol biosynthesis after simvastatin treatment, as indexed by a decrease of cerebrospinal fluid lathosterol and plasma 24S-hydroxycholesterol. Despite this effect, there were no changes in AD biomarkers. Our findings indicate that simvastatin treatment can affect brain cholesterol metabolism within 12 weeks, but did not alter molecular indices of AD pathology during this short-term treatment." @default.
- W2016068173 created "2016-06-24" @default.
- W2016068173 creator A5005504789 @default.
- W2016068173 creator A5023616587 @default.
- W2016068173 creator A5028236243 @default.
- W2016068173 creator A5040069088 @default.
- W2016068173 creator A5042247598 @default.
- W2016068173 creator A5063074309 @default.
- W2016068173 creator A5068688487 @default.
- W2016068173 creator A5071412244 @default.
- W2016068173 creator A5076725742 @default.
- W2016068173 creator A5090506611 @default.
- W2016068173 date "2010-07-01" @default.
- W2016068173 modified "2023-10-18" @default.
- W2016068173 title "Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers" @default.
- W2016068173 cites W1447623510 @default.
- W2016068173 cites W1847168837 @default.
- W2016068173 cites W1965050626 @default.
- W2016068173 cites W1965583284 @default.
- W2016068173 cites W1972485653 @default.
- W2016068173 cites W1974323476 @default.
- W2016068173 cites W1978841341 @default.
- W2016068173 cites W1981362787 @default.
- W2016068173 cites W1982823300 @default.
- W2016068173 cites W1984964878 @default.
- W2016068173 cites W1991952617 @default.
- W2016068173 cites W1995583689 @default.
- W2016068173 cites W1996375006 @default.
- W2016068173 cites W1998664054 @default.
- W2016068173 cites W2001361004 @default.
- W2016068173 cites W2003188394 @default.
- W2016068173 cites W2003753329 @default.
- W2016068173 cites W2003898971 @default.
- W2016068173 cites W2006166262 @default.
- W2016068173 cites W2009111659 @default.
- W2016068173 cites W2009145128 @default.
- W2016068173 cites W2015034968 @default.
- W2016068173 cites W2023713823 @default.
- W2016068173 cites W2024531656 @default.
- W2016068173 cites W2028436804 @default.
- W2016068173 cites W2029040938 @default.
- W2016068173 cites W2032890774 @default.
- W2016068173 cites W2034038074 @default.
- W2016068173 cites W2039934896 @default.
- W2016068173 cites W2046718416 @default.
- W2016068173 cites W2047613132 @default.
- W2016068173 cites W2049186585 @default.
- W2016068173 cites W2050881912 @default.
- W2016068173 cites W2064494564 @default.
- W2016068173 cites W2068114684 @default.
- W2016068173 cites W2068448803 @default.
- W2016068173 cites W2069746320 @default.
- W2016068173 cites W2076965707 @default.
- W2016068173 cites W2081586704 @default.
- W2016068173 cites W2089731024 @default.
- W2016068173 cites W2098878950 @default.
- W2016068173 cites W2099556509 @default.
- W2016068173 cites W2104933103 @default.
- W2016068173 cites W2104999604 @default.
- W2016068173 cites W2108326377 @default.
- W2016068173 cites W2123457140 @default.
- W2016068173 cites W2129379145 @default.
- W2016068173 cites W2131963133 @default.
- W2016068173 cites W2135631433 @default.
- W2016068173 cites W2138733401 @default.
- W2016068173 cites W2141362400 @default.
- W2016068173 cites W2145123193 @default.
- W2016068173 cites W2147782235 @default.
- W2016068173 cites W2148573574 @default.
- W2016068173 cites W2156220037 @default.
- W2016068173 cites W2157359173 @default.
- W2016068173 cites W2159529587 @default.
- W2016068173 cites W2169146425 @default.
- W2016068173 cites W4241136696 @default.
- W2016068173 cites W424467158 @default.
- W2016068173 doi "https://doi.org/10.1097/wad.0b013e3181d61fea" @default.
- W2016068173 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3694274" @default.
- W2016068173 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20473136" @default.
- W2016068173 hasPublicationYear "2010" @default.
- W2016068173 type Work @default.
- W2016068173 sameAs 2016068173 @default.
- W2016068173 citedByCount "53" @default.
- W2016068173 countsByYear W20160681732012 @default.
- W2016068173 countsByYear W20160681732013 @default.
- W2016068173 countsByYear W20160681732014 @default.
- W2016068173 countsByYear W20160681732015 @default.
- W2016068173 countsByYear W20160681732016 @default.
- W2016068173 countsByYear W20160681732017 @default.
- W2016068173 countsByYear W20160681732018 @default.
- W2016068173 countsByYear W20160681732019 @default.
- W2016068173 countsByYear W20160681732020 @default.
- W2016068173 countsByYear W20160681732021 @default.
- W2016068173 countsByYear W20160681732022 @default.
- W2016068173 countsByYear W20160681732023 @default.
- W2016068173 crossrefType "journal-article" @default.
- W2016068173 hasAuthorship W2016068173A5005504789 @default.
- W2016068173 hasAuthorship W2016068173A5023616587 @default.
- W2016068173 hasAuthorship W2016068173A5028236243 @default.